Greg Williams Email & Phone Number

• Population Health Partners is an investment firm bridging venture capital and private equity, committed to building great companies and generating superior returns for our investing partners by solving the health and.
• Validae Health is an organization within Population Health Partners. Its goal is to deliver valid evidence efficiently and it is central to PHP's ability to unlock outsized value from PHP investments.

Watertown, Massachusetts, US

• Set strategic direction and maximized enterprise value by driving clinical and preclinical rare disease programs in cystic fibrosis, Usher syndrome, ADPKD and other rare kidney diseases.
• Led the business through the COVID pandemic by developing and implementing multiple global risk mitigation strategies and achieving positive Phase 2 study results.

Watertown, Massachusetts, US

• As a key member of the C-suite team, raised $50M in capital and provided strategic operational leadership for preclinical, clinical, CMC and business activities.
• Regularly interfaced with the Board of Directors, led teams through global health authority interactions and preclinical evaluation of extensive compound library to expand corporate portfolio.

Boston, MA, US

• As the company’s 6th member, helped build the company from clinical stage to a full integrated commercial organization with 600 employees.
• Key member of management team achieving 2014’s highest returning IPO in any business segment and raising $1.05BN in capital.
• Expanded company footprint to include a New Jersey site and led teams to submit the company’s 1st NDA achieving a 1st-cycle approval for TYMLOS®.

East Hanover, NJ, US

• Co-led the development and implementation of global commercial strategies to launch and relaunch Cleviprex®.
• Co-inventor of a novel formulation with new IP securing 20 years of exclusivity and global health authority approvals.

East Hanover, NJ, US

• Led team developing health economic models demonstrating cost savings due to improved blood pressure control leading to expanded commercial acceptance.
• Co-designed and implemented new clinical trials to expand labeling and eligible patient populations.
• Co-led manufacturing process improvements and global health authority interactions enabling product reintroduction post-recall and additional global approvals.

East Hanover, NJ, US

• Built and led team with aggressive timelines to submit a high-quality NDA, gaining 1st-cycle FDA approval of novel IV antihypertensive.

Bedminster, New Jersey, US

• Led cross-functional organization to submit 1st NDA and MAA, leading to approval of Preotact®.
• Created company’s first cGXP compliance group and passed all pre-approval audits.

Bedminster, New Jersey, US

• Developed and implemented PM best practices for continuous business process optimization.
• Chaired Development Operating Committee governing portfolio review (4 NCEs) and led key alliance steering committee.

Master Of Business Administration (Mba)

Doctor Of Philosophy (Ph.D.), Biopharmaceutics

Master Of Science (Ms), Chemistry

Bachelor Of Science (Bs), Chemistry And Biology